PerkinElmer Inc to buy Germany's Euroimmun

By Ben Mouncer
PerkinElmer Inc is to buy Germany's Euroimmun Medical Laboratory Diagnostics AG in a deal worth $1.3bn. The scientific instruments maker is looking to...

PerkinElmer Inc is to buy Germany's Euroimmun Medical Laboratory Diagnostics AG in a deal worth $1.3bn.

The scientific instruments maker is looking to expand its reach into autoimmune and allergy diagnostic markets and Euroimmun is recognised as a lead autoimmune testing company in infectious disease and allergy testing.

It employs 2,400 members of staff and has recorded an average revenue growth of 19% over the last five years, generating sales in more than 130 countries worldwide.

45% of its revenues come in China, with the buy-out giving PerkinElmer Inc new infectious disease capabilities to its customers in the Asian country.

The deal could add up to $0.30 per share to Perkin Elmer Inc’s 2018 adjusted earnings, with the transaction expected to complete in the final quarter of this year.

First quarter numbers for Perkin Elmer Inc revealed revenues of $514.12m, nearly $8m up on the predicted figure of $506.81m.

Share

Featured Articles

UPS Healthcare Addressing Connected Logistics Needs

UPS Healthcare is meeting increased need for integrated, globally connected healthcare logistics services in Republic of Ireland, where pharma is booming

HPV Vaccine 'Protects Males from Cancers' - Global Report

As a new report shows the human papillomavirus vaccine can also protect men and boys, we take a look at HPV vaccines, and their impact on world health

Tata Consultancy Report Shows AI in Healthcare on Rise

Tata Consultancy Services AI for Business Global Study shows that three-quarters of healthcare leaders are deploying AI to drive innovation and efficiency

McKinsey: Consumers Demand Data-driven Wellness Products

Medical Devices & Pharma

SpaceX Starlink Launch Boost for Indonesia Healthcare

Technology & AI

J&J Targets Supplier Sustainability to Cut Healthcare GHGs

Sustainability